

RSV Unveiled: Breaking Down the New Vaccines on the Block
QPD Podcast por Cambiar Investors
T3 · E2
16 may 2024
16:10
Notas del episodio
In this episode of the QPD Podcast, Dr. Raymond Blum, a board-certified expert in internal medicine and infectious diseases, discusses the impact of respiratory syncytial virus (RSV).
We explore the revolutionary new vaccines, their development, effectiveness, and impact on public health.
Palabras clave
RSV
healthcare
vaccines
GSK
Arexvy
international stocks